Breakdown of multiple sclerosis genetics to identify an integrated disease network and potential variant mechanisms

被引:10
|
作者
Shepard, C. Joy [1 ,2 ]
Cline, Sara G. [1 ]
Hinds, David [3 ,4 ]
Jahanbakhsh, Seyedehameneh [4 ]
Prokop, Jeremy W. [4 ,5 ]
机构
[1] Athens State Univ, Dept Biol, Athens, AL USA
[2] Univ Alabama Birmingham, Grad Biomed Sci, Birmingham, AL USA
[3] HudsonAlpha Inst Biotechnol, Huntsville, AL USA
[4] Michigan State Univ, Dept Pediat & Human Dev, Coll Human Med, Grand Rapids, MI USA
[5] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA
基金
美国国家卫生研究院;
关键词
data integration; eQTL; GWAS; multiple sclerosis; omics; GENOME-WIDE ASSOCIATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RISK; SUSCEPTIBILITY; METAANALYSIS; RGS14; GFI1; AFF3; IDENTIFICATION; CONCORDANCE;
D O I
10.1152/physiolgenomics.00120.2018
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Genetics of multiple sclerosis (MS) are highly polygenic with few insights into mechanistic associations with pathology. In this study, we assessed MS genetics through linkage disequilibrium and missense variant interpretation to yield a MS gene network. This network of 96 genes was taken through pathway analysis, tissue expression profiles, single cell expression segregation, expression quantitative trait loci (eQTLs), genome annotations, transcription factor (TF) binding profiles, structural genome looping, and overlap with additional associated genetic traits. This work revealed immune system dysfunction, nerve cell myelination, energetic control, transcriptional regulation, and variants that overlap multiple autoimmune disorders. Tissue-specific expression and eQTLs of MS genes implicate multiple immune cell types including macrophages, neutrophils, and T cells, while the genes in neural cell types enrich for oligodendrocyte and myelin sheath biology. There are eQTLs in linkage with lead MS variants in 25 genes including the multitissue eQTL, rs9271640, for HLA-DRB1/DRB5. Using multiple functional genomic databases, we identified noncoding variants that disrupt TF binding for GABPA, CTCF, EGR1, YY1, SPI1, CLOCK, ARNTL, BACH1, and GFI1. Overall, this paper suggests multiple genetic mechanisms for MS associated variants while highlighting the importance of a systems biology and network approach when elucidating intersections of the immune and nervous system.
引用
收藏
页码:562 / 577
页数:16
相关论文
共 50 条
  • [41] Multiple Sclerosis disease distribution and potential impact of environmental air pollutants in Georgia
    Gregory, Anthony Charles, II
    Shendell, Derek G.
    Okosun, Ike S.
    Gieseker, Karen E.
    SCIENCE OF THE TOTAL ENVIRONMENT, 2008, 396 (01) : 42 - 51
  • [42] Potential Involvement of Peroxisome in Multiple Sclerosis and Alzheimer's Disease Peroxisome and Neurodegeneration
    Zarrouk, Amira
    Nury, Thomas
    El Hajj, Hammam I.
    Gondcaille, Catherine
    Andreoletti, Pierre
    Moreau, Thibault
    Cherkaoui-Malki, Mustapha
    Berger, Johannes
    Hammami, Mohamed
    Lizard, Gerard
    Vejux, Anne
    PEROXISOME BIOLOGY: EXPERIMENTAL MODELS, PEROXISOMAL DISORDERS AND NEUROLOGICAL DISEASES, 2020, 1299 : 91 - 104
  • [43] Nuclear receptors and autoimmune disease: The potential of PPAR agonists to treat multiple sclerosis
    Racke, MK
    Gocke, AR
    Muir, M
    Diab, A
    Drew, PD
    Lovett-Racke, AE
    JOURNAL OF NUTRITION, 2006, 136 (03) : 700 - 703
  • [44] Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer's Disease
    Tandon, Ankit
    Singh, Sangh Jyoti
    Chaturvedi, Rajnish Kumar
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [45] The Potential for Immunospecific Therapy in Multiple Sclerosis Based on Identification of Driver Clones of the Disease
    Gabaglia, Claudia Raja
    Booker, Abbigail T.
    Braciak, Todd A.
    CRITICAL REVIEWS IN IMMUNOLOGY, 2020, 40 (03) : 237 - 246
  • [46] The Blood-Brain Barrier-A Key Player in Multiple Sclerosis Disease Mechanisms
    Schreiner, Thomas Gabriel
    Romanescu, Constantin
    Popescu, Bogdan Ovidiu
    BIOMOLECULES, 2022, 12 (04)
  • [47] Do Cerebral Small Vessel Disease and Multiple Sclerosis Share Common Mechanisms of White Matter Injury?: A Genetic Study
    Brown, Robin B.
    Traylor, Matthew
    Burgess, Stephen
    Sawcer, Stephen
    Markus, Hugh S.
    STROKE, 2019, 50 (08) : 1968 - 1972
  • [48] Immune response profiling of HERV-W envelope proteins in multiple sclerosis: potential biomarkers for disease progression
    Ruberto, Stefano
    Dominguez-Mozo, Maria I.
    Garcia-Martinez, M. Angel
    Cossu, Davide
    Sechi, Leonardo A.
    Alvarez-Lafuente, Roberto
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [49] Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysis
    Levi, Izhak
    Gurevich, Michael
    Perlman, Gal
    Magalashvili, David
    Menascu, Shay
    Bar, Noam
    Godneva, Anastasia
    Zahavi, Liron
    Chermon, Danyel
    Kosower, Noa
    Wolf, Bat Chen
    Malka, Gal
    Lotan-Pompan, Maya
    Weinberger, Adina
    Yirmiya, Erez
    Rothschild, Daphna
    Leviatan, Sigal
    Tsur, Avishag
    Didkin, Maria
    Dreyer, Sapir
    Eizikovitz, Hen
    Titngi, Yamit
    Mayost, Sue
    Sonis, Polina
    Dolev, Mark
    Stern, Yael
    Achiron, Anat
    Segal, Eran
    CELL REPORTS MEDICINE, 2021, 2 (04)
  • [50] Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid
    Cicalini, Ilaria
    Rossi, Claudia
    Pieragostino, Damiana
    Agnifili, Luca
    Mastropasqua, Leonardo
    di Ioia, Maria
    De Luca, Giovanna
    Onofrj, Marco
    Federici, Luca
    Del Boccio, Piero
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (06):